Literature DB >> 2857852

Value of insulin autoantibodies as serum markers for insulin-dependent diabetes mellitus.

T Wilkin, P J Hoskins, M Armitage, M Rodier, C Casey, J L Diaz, D A Pyke, R D Leslie.   

Abstract

Insulin autoantibodies (IAA) were studied in newly diagnosed insulin-dependent diabetics before the start of insulin treatment and in unaffected identical twins of insulin-dependent diabetics. In 15 of the 40 (38%) diabetics and 27 of the 58 (47%) twins IAA levels exceeded those of 100 controls. Frequency of IAA in unaffected twins was not related to duration of diabetes in their affected twin. In 11 unaffected twins, IAA levels differed in two samples taken 1-12 years apart; IAA were detected at least once in all twins and in one on both occasions. IAA in the twins were not related to the presence of islet-cell antibodies or to HLA-DR 3 or 4. As the unaffected twins of longstanding diabetics are unlikely to develop diabetes, these observations suggest that IAA do not always presage diabetes and are probably not a consequence of the disease; they may reflect an inherited autoimmune tendency to diabetes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2857852     DOI: 10.1016/s0140-6736(85)92086-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  36 in total

Review 1.  The differentiation of the immune system towards anti-islet autoimmunity. Clinical prospects.

Authors:  C Boitard
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

2.  Insulin autoantibodies in non-obese diabetic (NOD) mice.

Authors:  C Michel; C Boitard; J F Bach
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

3.  Longitudinal epitope analysis of insulin-binding antibodies in type 1 diabetes.

Authors:  T R Hall; J W Thomas; C J Padoa; C Torn; M Landin-Olsson; E Ortqvist; C S Hampe
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

4.  Recognition of human insulin in vitro by T cells from subjects treated with animal insulins.

Authors:  L J Nell; V J Virta; J W Thomas
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

5.  Islet cell and insulin autoantibodies in subjects at high risk for development of type 1 (insulin-dependent) diabetes mellitus: the Lyon family study.

Authors:  C Thivolet; B Beaufrére; H Bétuel; L Gebuhrer; P Chatelain; A Durand; J Tourniaire; R François
Journal:  Diabetologia       Date:  1988-10       Impact factor: 10.122

6.  Predictors for cognitive impairment one year after surgery for aneurysmal subarachnoid hemorrhage.

Authors:  M Orbo; K Waterloo; A Egge; J Isaksen; T Ingebrigtsen; B Romner
Journal:  J Neurol       Date:  2008-10-07       Impact factor: 4.849

7.  Islet-cell antibodies as predictors of the later development of type 1 (insulin-dependent) diabetes. A study in identical twins.

Authors:  C Johnston; B A Millward; P Hoskins; R D Leslie; G F Bottazzo; D A Pyke
Journal:  Diabetologia       Date:  1989-06       Impact factor: 10.122

8.  Insulin autoantibodies in the pre-diabetic period: correlation with islet cell antibodies and development of diabetes.

Authors:  B M Dean; F Becker; J M McNally; A C Tarn; G Schwartz; E A Gale; G F Bottazzo
Journal:  Diabetologia       Date:  1986-05       Impact factor: 10.122

9.  Importance of persistent cellular and humoral immune changes before diabetes develops: prospective study of identical twins.

Authors:  R Y Tun; M Peakman; L Alviggi; M J Hussain; S S Lo; M Shattock; D A Pyke; G F Bottazzo; D Vergani; R D Leslie
Journal:  BMJ       Date:  1994-04-23

10.  Prolonged incubation in the two-colour immunofluorescence test increases the prevalence and titres of islet cell antibodies in type 1 (insulin-dependent) diabetes mellitus.

Authors:  M L Olsson; G Sundkvist; A Lernmark
Journal:  Diabetologia       Date:  1987-05       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.